N/A
Completed N=39
Quality of Life Impact of Nasal Airway Treatment With Aerin Medical Device
Source: ClinicalTrials.gov NCT03290300 ↗Enrolled (actual)
39
Serious AEs
0.0%
Results posted
Aug 2019
Primary outcomePrimary: Change From Baseline NOSE Score — 53.3; 48.1; 53.5 units on a scale — p=<0.0001
Summary
Evaluation of long-term (5-year) quality of life after nasal airway obstruction treatment with the Aerin Vivaer Stylus
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change From Baseline NOSE Score |
53.3; 48.1; 53.5 | <0.0001 sig |
| PRIMARY Change From Baseline NOSE Score - Long Term Extended Follow-up |
32.3; 25.7 | — |
| PRIMARY Number and Percentage of Participants With Positive Response on Quality of Life Assessment Items |
25; 22; 28; 20; 25; 25 | — |
Eligibility Criteria
Inclusion Criteria
- Received nasal obstruction treatment in Aerin Study TP 258
Exclusion Criteria
- Unwilling to participate in this long-term study
Data sourced from ClinicalTrials.gov (NCT03290300). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.